(Q73924199)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11371740%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Interleukin 12 secretion enhances antitumor efficacy of oncolytic herpes simplex viral therapy for colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11371740%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

1 reference

1 reference

J J Bennett

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11371740%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S Malhotra

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11371740%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

R J Wong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11371740%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

K Delman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11371740%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J Zager

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11371740%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M St-Louis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11371740%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P Johnson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11371740%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Y Fong

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11371740%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11371740%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11371740%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11371740%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

819-826

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11371740%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11371740%20AND%20SRC:MED&resulttype=core&format=json

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

7 November 2019

cites work

1 reference

12 December 2020

Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins

1 reference

12 December 2020

Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors

1 reference

12 December 2020

Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12.

1 reference

12 December 2020

Cancer statistics, 2000.

1 reference

12 December 2020

Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells

1 reference

12 December 2020

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

1 reference

12 December 2020

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

1 reference

12 December 2020

Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer

1 reference

12 December 2020

T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus.

1 reference

12 December 2020

Cytokine gene therapy for human tumors.

1 reference

12 December 2020

Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12.

1 reference

12 December 2020

Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors

1 reference

12 December 2020

Role of NK and T cells in IL-12-induced anti-tumor response against hepatic colon carcinoma

1 reference

12 December 2020

Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).

1 reference

12 December 2020

B-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cells

1 reference

12 December 2020

Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12

1 reference

12 December 2020

Clinical perspective of human colorectal cancer metastasis

1 reference

12 December 2020

Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant

1 reference

12 December 2020

In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents

1 reference

12 December 2020

Factor(s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant

1 reference

12 December 2020

A conserved open reading frame that overlaps the herpes simplex virus thymidine kinase gene is important for viral growth in cell culture

1 reference

12 December 2020

Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture

1 reference

12 December 2020

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

1 reference

12 December 2020

The gamma 1(34.5) gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells

1 reference

12 December 2020

Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes

1 reference

12 December 2020

Effects of IL-12 on helper T cell-dependent immune responses in vivo

1 reference

12 December 2020

A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes

1 reference

12 December 2020

Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant

1 reference

12 December 2020

Evidence that the herpes simplex virus type 1 uracil DNA glycosylase is required for efficient viral replication and latency in the murine nervous system

1 reference

12 December 2020

Selective destruction of gliomas in immunocompetent rats by thymidine kinase-defective herpes simplex virus type 1.

1 reference

12 December 2020

Surgical options in the treatment of hepatic metastasis from colorectal cancer

1 reference

12 December 2020

Association of a M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 134.5- mutants of her

1 reference

12 December 2020

Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas

1 reference

12 December 2020

IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts

1 reference

12 December 2020

Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus

1 reference

12 December 2020

Treatment of colorectal cancer: hepatic metastasis

1 reference

12 December 2020

Role of interleukin-12 (IL12) as an anti-tumour agent: experimental biology and clinical application

1 reference

12 December 2020

Use of a "replication-restricted" herpes virus to treat experimental human malignant mesothelioma

1 reference

12 December 2020

Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon

1 reference

12 December 2020

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.

1 reference

12 December 2020

Importance of the herpes simplex virus UL24 gene for productive ganglionic infection in mice.

1 reference

12 December 2020

An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma

1 reference

12 December 2020

10.1097/00000658-200106000-00012

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11371740%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference